Introduction: Postmenopausal uterine bleeding is a cancer until proven otherwise. Endometrial cancer is a typical disease among postmenopause woman, because every bleeding in this age etiology associated with endometrial cancer (10-30%). The lifespan of women today has been extended and post menopause today last one third of a womans life. Early diagnosis of endometrial cancer has a very high cure rate. Screening for this cancer has limits in practice and is necessary given the definition of high-risk groups would be subject to primary and secondary prevention. Goal: Primary to evaluate the leading causes of postmenopausal uterine bleeding among patients at risk for endometrial cancer (diabetes, obesity, nulliparity, late menopause (after 55 years) and compared them with the causes of postmenopausal uterine bleeding patients without this risk. Material and methods: A retrospective, descriptive study with a targeted sample of 50 consecutive patients who had registered postmenopausal uterine bleeding in high-risk groups (cohorts) and the same number of patients with postmenopausal uterine bleeding that does not belong to the risk group (control group). Each patient underwent clinical examination, then fractionated curettements and its histopathological verification and assessment of treated clinical stage of disease with PH analysis of the resected specimens. Results: The patients of the studied risk group were significantly affected by endometrial cancer compared with the control group (RR=2.45, 95% CI 1.2 4.6, p=0.005). Endocervical pathology did not differ between groups. Clinical forms of bleeding: for those that are profuse bleeding cancer was present in 54.6% of cases. With intermittent bleeding cancer is verified in the 33.3% of patients. Risk patient groups with cancer frequently suffer from clinically more advanced stages of histologically aggressive endometrial cancer (serous adenocarcinomatype II, low differentiated cancer).
postmenopausal bleeding, endometrial cancer, risk factors, clinical forms of bleeding.
extract promotes M2 polarization and reduces oligomeric amyloid-Î²-induced inflammatory reactions in microglial cells.
Sun ZQ, Liu JF, Luo W, Wong CH, So KF, Hu Y, Chiu K
Neural regeneration research. 2022; 17(1): 203-209
Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome.
Neural regeneration research. 2022; 17(2): 333-335
Central nervous system stimulation therapies in phantom limb pain: a systematic review of clinical trials.
Garcia-Pallero MÃ, Cardona D, Rueda-Ruzafa L, Rodriguez-Arrastia M, Roman P
Neural regeneration research. 2022; 17(1): 59-64
New sequential algorithm using Mac-2 binding protein glycosylation isomer to detect advanced carotid artery atherosclerosis.
Park H, Jun DW, Park HK, Park KY, Hwang HS
Annals of translational medicine. 2021; 9(7): 566
Circadian factors in comorbid insomnia and sleep apnea (COMISA).
Sweetman A, Reynolds A, Lack LC
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep M. 2021; ():